NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
53 hedge funds and large institutions have $143M invested in NKGen Biotech, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
53
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.96M | |
| 2 | +$7.33M | |
| 3 | +$5.22M | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$1.79M |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
+$1.76M |
Top Sellers
| 1 | -$5.1M | |
| 2 | -$1.59M | |
| 3 | -$1.29M | |
| 4 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
-$980K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$318K |